August 23, 2022
Young companies active in the life sciences industry, pitch your company and/or innovations at the Dutch Life Sciences conference. Increase your visibility, earn PR and connect to collaboration partners and investors.
July 12, 2022
Working together with the European Medicines Agency (EMA), College ter Beoordeling van Geneesmiddelen (CBG) and Centrale Commissie Mensgebonden Onderzoek (CCMO)
May 31, 2022
Take a look at which presentations are available to be downloaded.
May 31, 2022
During the Investors Forum ten young companies had the opportunity to present their company to interesting partners and discuss their business strategy, technology direction and capital-raising plan. On stage of the 17th edition of the Dutch Life Sciences Conference, SLAM Orthopedic became the proud winner of the Investors Forum Prize and was awarded a partnering ticket, national or international, with a total value of €2,500.
May 30, 2022
To succeed in the Biotechnology industry, human resources must be a true business partner. However, many starting and young companies still either do not have HR representation, or add these responsibilities to the busy schedule of an administrative assistant or finance officer. Usually the question is “can we afford to hire an HR representative”.
May 30, 2022
Update your knowledge of the ins and outs of dealing with intellectual property by watching a series of free IP webinars produced by V.O. Patents & Trademarks, partner of Dutch Life Sciences Conference 2022.
May 23, 2022
Due to Covid, last year’s winners of the Venture Challenge were announced today at the Dutch Life Sciences Conference. The proud winner of the 2021 summer edition is Sella Therapies. The innovative startup Sella Therapies has developed a novel therapy for chronic pain relief that targets the body’s internal neuropeptide system.
May 23, 2022
Due to Covid, last year’s winners of the Venture Challenge were announced today at the Dutch Life Sciences Conference. The proud winner of the fall edition is QurieGen, formerly known as Monoceros Analytics. The innovative startup QurieGen has developed a single-cell sequencing-based method to map the changes in transcriptome, membrane and 100’ of intracellular (phospho)proteins simultaneously across multiple pathways (IP filed) to obtain a high-resolution map of cellular response.